Literature DB >> 25149382

Effect of DC-CIK cell on the proliferation, apoptosis and differentiation of leukemia cells.

Hui-Qing Qu1, Xiao-Sheng Zhou2, Xiao-Long Zhou3, Jian Wang4.   

Abstract

OBJECTIVE: To observe the effect of co-culture cytokine-induced killer cells (CIK) and homologous dendritic cells (DC) on the proliferative activity and phenotype change of the DC-CIK cell and the cell killing activity of leukemia HL-60.
METHODS: 50 mL cord blood sample was obtained from infants delivered by full term healthy woman and the cord blood mononuclear cells were isolated by density gradient centrifugation. Non-adherent cells were collectedfor the induction culture of CIK, adherent cells were differentiated into mature DC; cultured mature DC was mixed with and CIK in the proportion of 1:5 for 12 d. Killing activity of DC-CIK co-cultured cell on leukemia HL-60 was detected by MTT assay.
RESULTS: Compared with CIKs, the co-cultured DC-CIKs presented a markedly higher proliferation and killing activity.
CONCLUSIONS: Co-culture of DC-CIK cells led to a significant increase of the proliferation and cytotoxicity of CIK.
Copyright © 2014 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adoptive; Adoptive immunotherapy; Dendritic cells; Fetal blood; HL-60; Immunotherapy

Mesh:

Substances:

Year:  2014        PMID: 25149382     DOI: 10.1016/S1995-7645(14)60111-5

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  12 in total

1.  Meta-analysis of chemotherapy and dendritic cells with cytokine-induced killer cells in the treatment of non-small-cell lung cancer.

Authors:  Chenhong Zheng; Ganjun Yu; Hui Wang; Airong Tang; Peiliang Geng; Huiming Zhang; Zhiquan Zhu; Fang Li; Xiaohua Xie
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Influence of autologous dendritic cells on cytokine-induced killer cell proliferation, cell phenotype and antitumor activity in vitro.

Authors:  Jingsong Cao; Cong Chen; Yuhuan Wang; Xuecheng Chen; Zeying Chen; Xiaoling Luo
Journal:  Oncol Lett       Date:  2016-07-11       Impact factor: 2.967

3.  The effects of hemocyanin on T cells cultured in vitro.

Authors:  Jiani Liu; Cong Chen; Chen Ling; Haoyun Hu; Jingsong Cao; Yongqiang Gao
Journal:  Oncol Lett       Date:  2017-12-11       Impact factor: 2.967

Review 4.  Dual Functional Capability of Dendritic Cells - Cytokine-Induced Killer Cells in Improving Side Effects of Colorectal Cancer Therapy.

Authors:  Paula Mosińska; Agata Gabryelska; Malwina Zasada; Jakub Fichna
Journal:  Front Pharmacol       Date:  2017-03-14       Impact factor: 5.810

5.  Chemotherapy plus dendritic cells co-cultured with cytokine-induced killer cells versus chemotherapy alone to treat advanced non-small-cell lung cancer: A meta-analysis.

Authors:  Cuiling Zhou; Donglan Liu; Jie Li; Huanhuan Sun; Xiaobin Zheng; Shuncong Wang; Guobin Hong; Saradhi Mallampati; Hongliu Sun; Xiuling Zhou; Zhibin Cheng; Hongyu Zhang; Haiqing Ma
Journal:  Oncotarget       Date:  2016-12-27

6.  Successful alternative treatment for relapsed adult acute lymphoblastic leukemia with dendritic cells-cytokine-induced killer cells combined with a rituximab-based regimen.

Authors:  XiaoFang Xiao; XingNong Ye; Cheng Xu; Jian Huang
Journal:  Onco Targets Ther       Date:  2018-10-29       Impact factor: 4.147

7.  Co-culture of dendritic cells and cytokine-induced killer cells effectively suppresses liver cancer stem cell growth by inhibiting pathways in the immune system.

Authors:  Tao Yang; Wenjun Zhang; Li Wang; Chunyan Xiao; Li Wang; Yi Gong; Dehong Huang; Bingling Guo; Qiying Li; Ying Xiang; Yingyu Nan
Journal:  BMC Cancer       Date:  2018-10-16       Impact factor: 4.430

8.  DC-CIK cells derived from ovarian cancer patient menstrual blood activate the TNFR1-ASK1-AIP1 pathway to kill autologous ovarian cancer stem cells.

Authors:  Wenxing Qin; Ying Xiong; Juan Chen; Yongyi Huang; Te Liu
Journal:  J Cell Mol Med       Date:  2018-03-22       Impact factor: 5.310

9.  The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors.

Authors:  Ying Wang; Zenghui Xu; Fuping Zhou; Yan Sun; Jingbo Chen; Linfang Li; Huajun Jin; Qijun Qian
Journal:  Exp Hematol Oncol       Date:  2015-11-10

10.  Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study.

Authors:  Ying Mu; Wei-Hua Wang; Jia-Ping Xie; Ying-Xin Zhang; Ya-Pei Yang; Chang-Hui Zhou
Journal:  Onco Targets Ther       Date:  2016-07-25       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.